In bladder cancer, TP53INP2 is upregulated and knockdown of TP53INP2 inhibits the invasion, migration as well as epithelial-to-mesenchymal transition (Zhou et al., 2020). The gene discussed is TP53INP2; the disease is urinary bladder carcinoma.